Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Close

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
American Journal of Rhinology|March 30, 2005
Effect of using multiple culture media for the diagnosis of noninvasive fungal sinusitisMelanie M Collins, Salil B Nair, Vanik Der-Haroutian, et al.
British Journal of Pharmacology|May 25, 2024
Subcutaneous administration of a novel TRPM8 antagonist reverses cold hypersensitivity while attenuating the drop in core body temperatureMichael S Gold, Jorge B Pineda-Farias, David Close, et al.
Journal of Chemical Biology|June 24, 2015
Design and activity of AP endonuclease-1 inhibitorsZhiwei Feng, Stanton Kochanek, David Close, et al.
British Journal of Clinical Pharmacology|February 19, 2020
Pharmacokinetics, pharmacodynamics and safety of the inverse retinoic acid-related orphan receptor γ agonist AZD0284Sara Asimus, Robert Palmér, Muna Albayaty, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 24, 2018
Mavrilimumab, a Fully Human Granulocyte-Macrophage Colony-Stimulating Factor Receptor α Monoclonal Antibody: Long-Term Safety and Efficacy in Patients With Rheumatoid ArthritisGerd R Burmester, Iain B McInnes, Joel M Kremer, et al.
Plos One|October 15, 2011
Discovery of diverse small molecule chemotypes with cell-based PKD1 inhibitory activityElizabeth R Sharlow, Gabriela Mustata Wilson, David Close, et al.
British Journal of Clinical Pharmacology|August 30, 2025
AZD0449, an inhaled JAK1 inhibitor, in healthy participants and patients with mild asthmaAnna Lundahl, Rod Hughes, Joachim Almquist, et al.
Plos Neglected Tropical Diseases|November 6, 2009
Identification of potent chemotypes targeting Leishmania major using a high-throughput, low-stringency, computationally enhanced, small molecule screenElizabeth R Sharlow, David Close, Tongying Shun, et al.
Rheumatology (Oxford, England)|October 26, 2017
Blockade of GM-CSF pathway induced sustained suppression of myeloid and T cell activities in rheumatoid arthritisXiang Guo, Brandon W Higgs, Anne-Christine Bay-Jensen, et al.
Archives of Toxicology|April 28, 2026
The immunogenic potential of AZD1402 (Elarekibep) T-cell epitopes in healthy volunteers and drug-exposed clinical trial participantsLiam Farrell, Stephanie M Bates, Alexander Walker, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
American Journal of Rhinology|March 30, 2005
Effect of using multiple culture media for the diagnosis of noninvasive fungal sinusitisMelanie M Collins, Salil B Nair, Vanik Der-Haroutian, et al.
British Journal of Pharmacology|May 25, 2024
Subcutaneous administration of a novel TRPM8 antagonist reverses cold hypersensitivity while attenuating the drop in core body temperatureMichael S Gold, Jorge B Pineda-Farias, David Close, et al.
Journal of Chemical Biology|June 24, 2015
Design and activity of AP endonuclease-1 inhibitorsZhiwei Feng, Stanton Kochanek, David Close, et al.
British Journal of Clinical Pharmacology|February 19, 2020
Pharmacokinetics, pharmacodynamics and safety of the inverse retinoic acid-related orphan receptor γ agonist AZD0284Sara Asimus, Robert Palmér, Muna Albayaty, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 24, 2018
Mavrilimumab, a Fully Human Granulocyte-Macrophage Colony-Stimulating Factor Receptor α Monoclonal Antibody: Long-Term Safety and Efficacy in Patients With Rheumatoid ArthritisGerd R Burmester, Iain B McInnes, Joel M Kremer, et al.
Plos One|October 15, 2011
Discovery of diverse small molecule chemotypes with cell-based PKD1 inhibitory activityElizabeth R Sharlow, Gabriela Mustata Wilson, David Close, et al.
British Journal of Clinical Pharmacology|August 30, 2025
AZD0449, an inhaled JAK1 inhibitor, in healthy participants and patients with mild asthmaAnna Lundahl, Rod Hughes, Joachim Almquist, et al.
Plos Neglected Tropical Diseases|November 6, 2009
Identification of potent chemotypes targeting Leishmania major using a high-throughput, low-stringency, computationally enhanced, small molecule screenElizabeth R Sharlow, David Close, Tongying Shun, et al.
Rheumatology (Oxford, England)|October 26, 2017
Blockade of GM-CSF pathway induced sustained suppression of myeloid and T cell activities in rheumatoid arthritisXiang Guo, Brandon W Higgs, Anne-Christine Bay-Jensen, et al.
Archives of Toxicology|April 28, 2026
The immunogenic potential of AZD1402 (Elarekibep) T-cell epitopes in healthy volunteers and drug-exposed clinical trial participantsLiam Farrell, Stephanie M Bates, Alexander Walker, et al.
Pageof 3